A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022)
        A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022).        
                  Expert Opinion on Therapeutic Patents.                
                  2023,
                
                              33(2),
                  
                              67-87,
                          
                  ISSN: 1354-3776,
                
                
                              PMID: 36975020,                          
                
                          
        
      
    